Osaic Holdings’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-150
| Closed | -$198 | – | 7482 |
|
|
2024
Q3 | $198 | Hold |
150
| – | – | ﹤0.01% | 6953 |
|
|
2024
Q2 | $1.14K | Sell |
150
-137
| -48% | -$1.04K | ﹤0.01% | 6591 |
|
|
2024
Q1 | $2.58K | Sell |
287
-156
| -35% | -$1.4K | ﹤0.01% | 6230 |
|
|
2023
Q4 | $4.75K | Sell |
443
-180
| -29% | -$1.93K | ﹤0.01% | 6123 |
|
|
2023
Q3 | $3.74K | Buy |
623
+50
| +9% | +$300 | ﹤0.01% | 6309 |
|
|
2023
Q2 | $3.95K | Sell |
573
-415
| -42% | -$2.86K | ﹤0.01% | 6331 |
|
|
2023
Q1 | $15.5K | Buy |
988
+8
| +0.8% | +$126 | ﹤0.01% | 5692 |
|
|
2022
Q4 | $19K | Sell |
980
-49
| -5% | -$950 | ﹤0.01% | 5599 |
|
|
2022
Q3 | $19K | Sell |
1,029
-100
| -9% | -$1.85K | ﹤0.01% | 5614 |
|
|
2022
Q2 | $25K | Sell |
1,129
-50
| -4% | -$1.11K | ﹤0.01% | 5459 |
|
|
2022
Q1 | $32K | Buy |
1,179
+87
| +8% | +$2.36K | ﹤0.01% | 5392 |
|
|
2021
Q4 | $50K | Sell |
1,092
-312
| -22% | -$14.3K | ﹤0.01% | 5145 |
|
|
2021
Q3 | $117K | Buy |
1,404
+131
| +10% | +$10.9K | ﹤0.01% | 4395 |
|
|
2021
Q2 | $121K | Buy |
1,273
+908
| +249% | +$86.3K | ﹤0.01% | 4320 |
|
|
2021
Q1 | $61K | Buy |
365
+115
| +46% | +$19.2K | ﹤0.01% | 4732 |
|
|
2020
Q4 | $25K | Buy |
+250
| New | +$25K | ﹤0.01% | 4996 |
|